Shorla Oncology INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
SAM.gov UEIKGTRN134AM61
Shorla Oncology develops and commercializes oncology drugs, with a product portfolio that includes TEPYLUTE, IMKELDI, JYLAMVO, and Nelarabine Injection. The company focuses on cancer indications where existing treatments are limited, in shortage, or inadequate for the target population.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Shorla Oncology INC | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.